Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
- PMID: 39565988
- DOI: 10.1056/NEJMoa2313472
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
Abstract
Background: Subacute and chronic subdural hematomas are common and frequently recur after surgical evacuation. The effect of adjunctive middle meningeal artery embolization on the risk of reoperation remains unclear.
Methods: In a prospective, multicenter, interventional, adaptive-design trial, we randomly assigned patients with symptomatic subacute or chronic subdural hematoma with an indication for surgical evacuation to undergo middle meningeal artery embolization plus surgery (treatment group) or surgery alone (control group). The primary end point was hematoma recurrence or progression that led to repeat surgery within 90 days after the index treatment. The clinical secondary end point was deterioration of neurologic function at 90 days, which was assessed with the modified Rankin scale in a noninferiority analysis (margin for risk difference, 15 percentage points).
Results: A total of 197 patients were randomly assigned to the treatment group and 203 to the control group. Surgery occurred before randomization in 136 of 400 patients (34.0%). Hematoma recurrence or progression leading to repeat surgery occurred in 8 patients (4.1%) in the treatment group, as compared with 23 patients (11.3%) in the control group (relative risk, 0.36; 95% confidence interval [CI], 0.11 to 0.80; P = 0.008). Functional deterioration occurred in 11.9% of the patients in the treatment group and in 9.8% of those in the control group (risk difference, 2.1 percentage points; 95% CI, -4.8 to 8.9). Mortality at 90 days was 5.1% in the treatment group and 3.0% in the control group. By 30 days, serious adverse events related to the embolization procedure had occurred in 4 patients (2.0%) in the treatment group, including disabling stroke in 2 patients; no additional events had occurred by 180 days.
Conclusions: Among patients with symptomatic subacute or chronic subdural hematoma with an indication for surgical evacuation, middle meningeal artery embolization plus surgery was associated with a lower risk of hematoma recurrence or progression leading to reoperation than surgery alone. Further study is needed to evaluate the safety of middle meningeal artery embolization in the management of subdural hematoma. (Funded by Medtronic; EMBOLISE ClinicalTrials.gov number, NCT04402632.).
Copyright © 2024 Massachusetts Medical Society.
Comment in
-
Middle Meningeal Artery Embolization for Subdural Hematoma.N Engl J Med. 2025 Mar 13;392(11):1143. doi: 10.1056/NEJMc2416123. N Engl J Med. 2025. PMID: 40073320 No abstract available.
-
Middle Meningeal Artery Embolization for Subdural Hematoma. Reply.N Engl J Med. 2025 Mar 13;392(11):1143. doi: 10.1056/NEJMc2416123. N Engl J Med. 2025. PMID: 40073321 No abstract available.
-
Middle Meningeal Artery Embolization for Subdural Hematoma. Reply.N Engl J Med. 2025 Mar 13;392(11):1143-1144. doi: 10.1056/NEJMc2416123. N Engl J Med. 2025. PMID: 40073322 No abstract available.
-
Middle Meningeal Artery Embolization for Subdural Hematoma. Reply.N Engl J Med. 2025 Mar 13;392(11):1144. doi: 10.1056/NEJMc2416123. N Engl J Med. 2025. PMID: 40073323 No abstract available.
Similar articles
-
Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma.N Engl J Med. 2025 Feb 27;392(9):855-864. doi: 10.1056/NEJMoa2409845. Epub 2024 Nov 20. N Engl J Med. 2025. PMID: 39565980 Clinical Trial.
-
Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma.N Engl J Med. 2024 Nov 21;391(20):1901-1912. doi: 10.1056/NEJMoa2401201. N Engl J Med. 2024. PMID: 39565989 Clinical Trial.
-
Comparison of adjunctive middle meningeal artery embolization using embosphere particles versus surgical drainage alone for the treatment of chronic subdural hematoma: A prospective study.J Clin Neurosci. 2024 Oct;128:110808. doi: 10.1016/j.jocn.2024.110808. Epub 2024 Aug 22. J Clin Neurosci. 2024. PMID: 39178697
-
Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-analysis.AJNR Am J Neuroradiol. 2023 Mar;44(3):297-302. doi: 10.3174/ajnr.A7796. Epub 2023 Feb 16. AJNR Am J Neuroradiol. 2023. PMID: 36797028 Free PMC article.
-
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review.World Neurosurg. 2019 Feb;122:613-619. doi: 10.1016/j.wneu.2018.11.167. Epub 2018 Nov 24. World Neurosurg. 2019. PMID: 30481628
Cited by
-
Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials.Acta Neurochir (Wien). 2025 Jun 2;167(1):160. doi: 10.1007/s00701-025-06574-9. Acta Neurochir (Wien). 2025. PMID: 40455367 Free PMC article. Review.
-
Can antithrombotic therapy be safely resumed after middle meningeal artery embolization with or without surgery for chronic subdural hematoma? a systematic review and meta-analysis.Acta Neurochir (Wien). 2025 Jul 3;167(1):183. doi: 10.1007/s00701-025-06600-w. Acta Neurochir (Wien). 2025. PMID: 40608194 Free PMC article.
-
Efficacy of atorvastatin-based treatment in super-aged patients with chronic subdural hematoma: a case series and literature review.Front Neurol. 2025 Jun 27;16:1609514. doi: 10.3389/fneur.2025.1609514. eCollection 2025. Front Neurol. 2025. PMID: 40656981 Free PMC article.
-
Advances in Cerebrovascular Imaging and Interventions.Diagnostics (Basel). 2025 Apr 20;15(8):1045. doi: 10.3390/diagnostics15081045. Diagnostics (Basel). 2025. PMID: 40310403 Free PMC article.
-
Critical Procedural Anatomy of High-Risk External Carotid Artery-Internal Carotid Artery Anastomoses.Semin Intervent Radiol. 2025 Mar 31;42(2):190-195. doi: 10.1055/s-0045-1806854. eCollection 2025 Apr. Semin Intervent Radiol. 2025. PMID: 40376218 Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical